Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LONP1 | P36776 | 13/20 | 0.61 |
| ▸ | PSMB5 | P28074 | 10/20 | 0.59 |
| ▸ | PSMB11 | A5LHX3 | 8/20 | 0.58 |
| ▸ | PSMA7 | O14818 | 8/20 | 0.58 |
| ▸ | PSMB1 | P20618 | 8/20 | 0.58 |
| ▸ | PSMA1 | P25786 | 8/20 | 0.58 |
| ▸ | PSMA2 | P25787 | 8/20 | 0.58 |
| ▸ | PSMA3 | P25788 | 8/20 | 0.58 |
| ▸ | PSMA4 | P25789 | 8/20 | 0.58 |
| ▸ | PSMB8 | P28062 | 8/20 | 0.58 |
| ▸ | PSMB9 | P28065 | 8/20 | 0.58 |
| ▸ | PSMA5 | P28066 | 8/20 | 0.58 |
| ▸ | PSMB4 | P28070 | 8/20 | 0.58 |
| ▸ | PSMB6 | P28072 | 8/20 | 0.58 |
| ▸ | PSMB10 | P40306 | 8/20 | 0.58 |
| ▸ | PSMB3 | P49720 | 8/20 | 0.58 |
| ▸ | PSMB2 | P49721 | 8/20 | 0.58 |
| ▸ | PSMA6 | P60900 | 8/20 | 0.58 |
| ▸ | PSMA8 | Q8TAA3 | 8/20 | 0.58 |
| ▸ | PSMB7 | Q99436 | 8/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28349151 | 1.00 | LONP1 (0.61) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL28372068 | 0.96 | LONP1 (0.58) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2125847 | 0.95 | LONP1 (0.63) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2125581 | 0.91 | LONP1 (0.59) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL1913443 | 0.86 | PSMB5 (0.76) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2125752 | 0.86 | PSMB5 (0.76) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2127712 | 0.86 | PSMB5 (0.63) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2127762 | 0.84 | PSMB5 (0.73) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL2126381 | 0.84 | PSMB5 (0.72) | LONP1PSMB5PSMB11PSMA7PSMB1 | |
| SCHEMBL22610052 | 0.84 | LONP1 (0.51) | LONP1PSMB5PSMB11PSMA7PSMB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159471-A1 | PYRAZINOIC ACID CONJUGATES AND HYBRID CONJUGATES | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159471-A1 | PYRAZINOIC ACID CONJUGATES AND HYBRID CONJUGATES | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-11584725-B2 | Pyrazinoic acid conjugates and hybrid conjugates | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2023-02-21 | — | — | US | disclosed |
| US-20200140397-A1 | PYRAZINOIC ACID CONJUGATES AND HYBRID CONJUGATES | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. | 2020-05-07 | — | — | US | disclosed |
| CN-108929340-B | Proline boric acid compound and preparation method and application thereof | 北京大学 | 2019-12-13 | — | — | CN | disclosed |
| EP-2444411-B1 | TRIPEPTIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | UNIV BEIJING (CN) | 2016-10-26 | — | — | EP | disclosed |
| US-9421237-B2 | Tripeptide boronic acid or boronic ester, preparative method and use thereof | PEKING UNIVERSITY (CN) | 2016-08-23 | — | — | US | disclosed |
| US-20120135921-A1 | TRIPETIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | PEKING UNIVERSITY (CN) | 2012-05-31 | — | — | US | disclosed |
| EP-2444411-A1 | TRIPEPTIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | Peking University (CN) | 2012-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584725-B2 | Pyrazinoic acid conjugates and hybrid conjugates | QPCT, RARA, PNKP | LONP1 3776/4885PSMB5 2826/4885PSMB11 2730/4885 |
| US-20200140397-A1 | PYRAZINOIC ACID CONJUGATES AND HYBRID CONJUGATES | QPCT, RARA, PNKP | LONP1 3776/4885PSMB5 2826/4885PSMB11 2730/4885 |
| US-20120135921-A1 | TRIPETIDE BORONIC ACID OR BORONIC ESTER, PREPARATIVE METHOD AND USE THEREOF | BTD, PSMB11, IAPP | LONP1 274/4885PSMB5 12/4885PSMB11 2/4885 |
| US-20230159471-A1 | PYRAZINOIC ACID CONJUGATES AND HYBRID CONJUGATES | QPCT, RARA, PNKP | LONP1 3776/4885PSMB5 2826/4885PSMB11 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.